Abstract
In the SORT OUT IX trial, the biolimus A9-coated BioFreedom stent, a stainless steel drug-coated stent devoid of polymer (BF-BES), did not show noninferiority to the biodegradable polymer ultrathin strut sirolimus-eluting Orsiro stent (O-SES). The aim of this substudy was to compare the clinical
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have